"There is reason to believe an oral therapy for Ulcerative Colitis which can involve the entire colon may be effective for Ulcerative Proctitis which involves the distal 20% or so."
Did they not actually come out and say that (instead providing some kind of acronym Jumble for people to figure out for themselves) in order to avoid bringing any unwanted attention to that prospect? Or does one of their BP NDAs require that they make it as vague as humanly possible?
You have shown that some have a DESIRE to believe that an oral therapy for Ulcerative Colitis which can involve the entire colon may be effective for Ulcerative Proctitis which involves the distal 20% or so, but the Company itself hasn't clearly expressed such a belief in any of THEIR language.
Lots of opportunities for the company, just need to capitalize on one. Getting that first deal/partnership will be huge and not just for the money, but for the validation of the company and drugs.